By / February 12, 2020

Zenabis cannabis production increased significantly

Things are going well for the cannabis producer Zenabis, at least at its New Brunswick plant in Atholville.

Zenabis Global Inc. has the potential to become one of the world’s largest licensed medical and recreational cannabis growers. The company is diverse, owns a dedicated team of physicians, scientists, researchers, farmers, educators and supporters who have come together with the goal of increasing access for medical patients and recreational users to healthy, high-quality cannabis. The company’s four facilities are located in Delta and Langley, British Columbia, coast-to-coast throughout Canada; Atholville, New Brunswick; and Stellarton, NS.

This week, the company unveiled its production figures for December, and it was able to paint a global picture of its cannabis production for the whole of the last year. Unsurprisingly, it is at the Atholville plant – the largest of the lot – where the largest quantity of cannabis was grown. brings you all the latest news, developments, and stories from the B2B industry that are vital to the growth and commercial applications of hemp in the U.S. and abroad. Either finding knowledge about business opportunities, manufacturing and processing best practices, or the status of legal or policy changes, experts in all facets of the hemp industry can gain insight and information.

Zenabis cannabis harvest significantly increased in December

The Restigouche plant harvested nearly 20,000 kg of cannabis, 20% of which was harvested in December alone, the largest harvest of the year. In fact, production figures have been steadily increasing throughout the year, rising from a meager 474 kg in January to 3841 kg in December. One of the reasons for this considerable difference is that the plant did not reach its full expansion potential (number of production rooms) until last September.

The aim of Zenabis Global Inc. is to harvest even more cannabis in 2020. (Source)

According to Jonathan Anthony, a spokesperson for the company “The year 2019 has been an exceptional year in Atholville and the team there has done a tremendous amount of work, particularly in completing the expansion and reaching full production.”

Greater production leads to greater sales

Since the Restigouche plant seems to have reached its cruising speed, the management of the plant believes it is realistic to expect a production of 40,000 kg to 45,000 kg in 2020. According to Mr. Anthony, this is good news since greater production means greater sales power.

In that regard, this week, Zenabis just shipped the very first batch of a new product, spray cartridges, to Nova Scotia. These cartridges are produced at the Atholville plant, which also has an extraction laboratory. The laboratory allows the dried cannabis flowers to be taken and distilled, in order to be used for derivative products, such as oil, capsules or, as in this case, cartridges for vaping.

For now, Zenabis cartridges are only available in Nova Scotia

As Anthony added: “We do not produce the vaporizers, but the cartridges that are compatible with the PAX Era type. For the moment, these cartridges are only available in Nova Scotia, but they will also be available in New Brunswick within a few weeks under the Namaste label. We’re very excited about this development as there aren’t many cannabis cartridge producers in the country yet.”

Zenabis’ spokesperson maintains that other products – notably consumables and beverages – could be added to the company’s portfolio in the coming months.


(Featured image by  Sharon McCutcheon via Unsplash)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in acadie35nouvelle, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.

Comments are closed for this post.